NEW YORK, NY / ACCESSWIRE / November 13, 2020 / PDS Biotechnology Corporation (NASDAQ:PDSB), a clinical-stage immunotherapy company developing novel cancer therapies and infectious disease vaccines based on the Company's proprietary Versamune ® T-cell activating technology, today announced that Dr. Frank Bedu-Addo, Chief Executive Officer, will be presenting at this year's virtual Fall Investor Summit taking place November 16 th -18 th , 2020. The Company's presentation will take place on...